Israeli breakthrough may lead to new epilepsy treatment
A drug targeting the enzyme DHODH could correct the abnormal set point of the ‘thermostat’ in the brain cells of epileptic patients.
APRIL 30, 2019, 12:01 PM
Abigail Klein Leichman is a writer and associate editor at ISRAEL21c. Prior to moving to Israel in 2007, she was a specialty writer and copy editor at a major daily newspaper in New Jersey and has freelanced for a variety of newspapers and periodicals since 1984.
No hay comentarios:
Publicar un comentario